Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,569,793
+$9,116,569 QoQ
Shares Held
892,663
-3.0% QoQ
Ownership
0.360%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#49
of 754 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $433,918,027 across 48 Biotechnology names. EXEL ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
719,545 | $81,567,621 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105,165 | $65,574,584 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
739,273 | $57,862,897 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
892,663 | $48,569,793 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
1,349,465 | $47,757,566 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
112,014 | $26,992,013 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
120,702 | $22,605,070 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
42,051 | $12,658,612 |
All Filings in EXEL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,569,793 | 892,663 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $39,453,224 | 919,870 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,751,942 | 724,434 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,444,943 | 834,018 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $37,296,705 | 846,114 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,650,242 | 559,324 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,247,571 | 427,855 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,823,406 | 301,480 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,689,493 | 253,204 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,846,425 | 204,232 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,751,916 | 156,395 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,240,507 | 148,307 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,175,501 | 113,841 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,443,583 | 125,893 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,937,098 | 245,455 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,362,215 | 86,876 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,626,645 | 78,129 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $567,770 | 25,045 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $387,938 | 21,222 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $647,497 | 30,629 | Shares | Sole | 2021-11-15 | |
| 2020-09-30 | $823,133 | 33,666 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $880,801 | 37,102 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $843,900 | 49,007 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||